DailyIQ
|
Sector:Financial ServicesAll sectors
Last updated 1 minute ago

AFL·Aflac Incorporated

$.
-. (-.%)
After Hours
High
$113.80
Open
$112.54
Market Cap
57.75B
52W High
$119.81
Low
$111.91
P. Close
$112.42
P/E
12.46
52W Low
$96.95
Fwd P/E
-
Mean Target
$112.43
Technical Score (1D)
50
NEUTRAL
News Sentiment
53
MIXED
Aflac Incorporated (AFL) saw a modest 0.9% decrease following its latest earnings report, indicating a subdued market reaction to its recent financial disclosures. Investors are likely evaluating these results in the context of broader market conditions and sector-specific challenges. The precise factors driving this stock movement warrant further examination, with the earnings call transcript and forward guidance being key areas for deeper analysis.
Earnings Summary
Aflac Incorporated is a prominent provider of supplemental insurance products, operating significantly in both the United States and Japan, offering policies that complement existing health and life insurance. The company's business spans various insurance solutions, including cancer, medical, and life insurance in Japan, and accident, disability, critical illness, dental, vision, and life insurance in the U.S., distributing through a diverse network. In the most recent reporting period, Q1 2026, Aflac reported actual EPS of $1.75 against an estimate of $1.8334, and actual revenue of $4.242 billion against an estimate of $4.2496 billion, indicating a slight miss on both metrics. This follows a Q4 2025 where actual EPS was $1.57 against an estimate of $1.7117, with actual revenue of $4.866 billion exceeding the estimate of $4.3487 billion. Comparing the last two reported quarters (Q4 2025 and Q1 2026) to the two prior quarters (Q2 2025 and Q3 2025), there is a mixed trend; Q2 2025 saw actual EPS of $1.78 beat its estimate of $1.70578, and Q3 2025 saw a significant beat with actual EPS of $2.49 against an estimate of $1.77653, while revenue figures for these earlier quarters were not provided. The recent performance shows a deceleration in EPS beats compared to the prior two quarters, with Q4 2025 and Q1 2026 both missing analyst EPS expectations. Historically, Aflac has demonstrated a pattern of revenue growth, as seen in Q4 2025's strong revenue beat, even when EPS estimates were missed. The company has a history of missing revenue estimates, making the Q4 2025 performance a notable exception. Recent news highlights Aflac's expansion of its "Check for Cancer" initiative and its recognition as Corporate Partner of the Year by the American Cancer Society, underscoring its commitment to public health and preventive care. However, analysis also points to potential headwinds, including contracting net premiums earned over five years and projected sales declines, alongside a prospectus filed for a significant resale of shares. Moving forward, investors will be watching for stabilization in revenue trends and continued commentary on the impact of its health initiatives, particularly in light of the recent EPS misses and potential market supply increases.

EPS

EstBeatMiss
$1.43$1.73$2.03$2.33$2.63Q1'25Q2'25Q3'25Q4'25Q1'26
QtrEstActual+/−
Q1'26$1.83$1.75-4.5%
Q4'25$1.71$1.57-8.3%
Q3'25$1.78$2.49+40.2%
Q2'25$1.71$1.78+4.4%
Q1'25$1.67$1.66-0.8%

Revenue

EstBeatMiss
$4.1B$4.4B$4.6B$4.8B$5.0BQ1'25Q2'25Q3'25Q4'25Q1'26
QtrEstActual+/−
Q1'26$4.2B$4.2B-0.2%
Q4'25$4.3B$4.9B+11.9%
Q3'25 - $4.4B -
Q2'25 - $4.5B -
Q1'25 - $4.3B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

AFL Stock Snapshot

AFL is currently trading at $112.50, giving Aflac Incorporated a market cap of 57.75B and a P/E ratio of 12.5. Today's range spans $111.91–$113.80, with shares opening at $112.54 and moving up $0.08 (0.1%) from the prior close. DailyIQ's technical score sits at 50/100 (HOLD) with a news sentiment reading of 53/100.

Over the past year AFL has traded between $96.95 and $119.81 - the current price is +16.0% off the 52-week low and -6.1% from the high. 23 analysts cover the stock with a Hold consensus and a mean 12-month target of $112.43 (range $99.00–$130.00), implying downside of -0.1%.

Neutral technical setups in large-cap Financial Services names are inherently unstable - they resolve. Right now, AFL (50/100, HOLD, price $112.50, in the upper portion of its 52-week range) is waiting for that resolution. Sentiment: neutral at 53/100. The current P/E ratio stands at 12.5. With 57.75B in market cap, the 52-week range of $96.95–$119.81 is where structural support and resistance live - and which one holds when the next catalyst hits will define the next trade.

The 52-week range of $96.95–$119.81 for AFL provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to — and at $112.50 (in the upper portion of its 52-week range), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 50/100 and neutral news backdrop (53/100) don't break the tie yet, but they narrow the probability distribution toward the upside.